Business Context and Reporting Period
Company: Harvard Bioscience, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: July 27, 2017
Reporting Period: The filing announces financial results for the three and six months ended June 30, 2017.
Key Financial Metrics
The provided text serves as a cover document referencing a press release (Exhibit 99.1) for detailed data. The filing text itself does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity.
- Revenue, Profit, Cash Flow: Not provided in the filing text.
- Margins, Debt, Liquidity: Not provided in the filing text.
Material Changes
The filing text does not provide specific data to compare current period performance against prior comparable periods. It only confirms the issuance of results for the periods ended June 30, 2017.
Guidance, Outlook, and Management Commentary
Management Action: On July 27, 2017, the company issued a press release and scheduled a conference call for 4:30 PM EST to discuss the results.
Legal Disclaimer: The information in Item 2.02 and the attached press release is furnished but not deemed "filed" under Section 18 of the Exchange Act and is not subject to the liabilities of that section, nor is it incorporated by reference in other filings unless expressly stated.
Investor Verification Checklist
- Review Exhibit 99.1 (the Press Release) for specific revenue, net income, and cash flow figures for the three and six months ended June 30, 2017.
- Verify year-over-year growth rates and margin trends in the press release, as they are absent from this 8-K summary text.
- Check the conference call transcript (held July 27, 2017) for management commentary on future guidance and operational risks.
- Confirm the company's liquidity position and debt obligations in the full financial statements referenced by the press release.